Related Experiment Video

Updated: Aug 25, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K

A practical approach to the guideline-directed pharmacological treatment of heart failure with reduced ejection

Amr Abdin1, Johann Bauersachs2, Samira Soltani2

  • 1Department of Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, Saarland University Medical Center, Saarland University, Saarbrücken, Germany.

ESC Heart Failure
|October 14, 2022
PubMed

Insights

Heart failure (HF) drug therapy needs optimization in real-world settings. This study proposes a practical algorithm to help physicians safely implement guideline-directed medical therapy for improved heart failure patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Heart failure (HF) affects over 64 million globally, despite recent pharmacotherapy advancements.
  • Current real-world HF treatment often uses suboptimal drug doses, potentially due to safety concerns and physician inertia.
  • Many HF patients do not receive all evidence-based medications that could improve prognosis.

Purpose of the Study:

  • To propose a practical algorithm for implementing guideline-directed medical therapy (GDMT) in heart failure patients.
  • To support physicians in optimizing pharmacotherapy for heart failure with reduced ejection fraction (HFrEF) in daily practice.
  • To address the lack of detailed recommendations for inpatient HF drug implementation in recent guidelines.

Main Methods:

  • Development of a practical, evidence-based treatment algorithm for HF pharmacotherapy.
  • Focus on optimizing guideline-directed chronic HF medical therapy for improved patient outcomes.
  • Algorithm designed to balance safety and efficacy in treating HF patients.

Main Results:

  • The proposed algorithm aims to facilitate the safe and effective use of GDMT in HF patients.
  • It addresses the gap in current guidelines regarding inpatient HF pharmacotherapy implementation.
  • The approach is intended to improve physician adherence to optimal dosing and drug class utilization.

Conclusions:

  • Optimizing HF pharmacotherapy is crucial for improving patient outcomes globally.
  • A practical algorithm can aid physicians in overcoming barriers to effective GDMT in heart failure.
  • The proposed approach supports evidence-based treatment for millions of heart failure patients worldwide.

Keywords:
AlgorithmHeart failureOutcomesTherapy

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.4K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
417
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27